AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Elevance Health Inc.

$423.73 +$69.48 (+19.61%)
NYSE · 14 Sep 2026 16:02 UTC
Previous Close
$418.72
Day Range
$420.28$427.17
Year Range
$274.84$436.24
Market Cap
91.89B
AVG Volume
1.46M
Trailing/Forward PE
18.83/14.3
PEG ratio
2.06
Dividend Yield
1.62%
Next Earnings Date
2026-10-21
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
050B100B150B200B2016201720182019202020212022202320242025
ELV Revenue (USD) by year
PeriodRevenue (USD)
2025199.12B
2024176.81B
2023171.34B
2022156.59B
2021138.64B
2020121.87B
2019104.21B
201892.11B
201790.04B
201684.89B
Net Income (USD)
02B4B6B8B2016201720182019202020212022202320242025
ELV Net Income (USD) by year
PeriodNet Income (USD)
20255.66B
20245.98B
20235.99B
20225.89B
20216.1B
20204.57B
20194.81B
20183.75B
20173.84B
20162.47B
Operating Income (USD)
02.5B5B7.5B10B2016201720182019202020212022202320242025
ELV Operating Income (USD) by year
PeriodOperating Income (USD)
20258.11B
20248.89B
20238.74B
20228.45B
20218.72B
20207.06B
20196.73B
20185.83B
20174.99B
20164.95B
EBITDA (USD)
05B10B15B2016201720182019202020212022202320242025
ELV EBITDA (USD) by year
PeriodEBITDA (USD)
20259.66B
202410.48B
202310.49B
202210.13B
202110.03B
20208.18B
20197.86B
20186.95B
20174.7B
20165.88B
Cash Flows (USD)
02.5B5B7.5B10B2016201720182019202020212022202320242025
ELV Cash Flows (USD) by year
PeriodCash Flows (USD)
20253.17B
20244.55B
20236.76B
20227.25B
20217.28B
20209.67B
20194.98B
20182.62B
20173.39B
20162.62B
EPS (USD)
01020302016201720182019202020212022202320242025
ELV EPS (USD) by year
PeriodEPS (USD)
202525.12
202425.61
202325.17
202224.26
202124.72
202017.91
201918.44
201814.2
201714.36
20169.21
Expenses (USD)
02B4B6B8BSG&ACapex2016201720182019202020212022202320242025
ELV Expenses (USD) by year
PeriodExpenses (USD)
20251.12B
20241.26B
20231.3B
20221.15B
20211.09B
20201.02B
20191.08B
20181.21B
2017793.5M
20166.75B
Cash & Debt (USD)
010B20B30B40BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
ELV Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20259.49B
20248.29B
20236.53B
20227.39B
20214.88B
20205.74B
20194.94B
20183.93B
20173.61B
201622.72B
Debt ratios
00.20.40.60.820182019202020212022202320242025
ELV Debt ratios by year
PeriodDebt ratios
20250.58
20240.59
20230.52
20220.51
20210.61
20200.58
20190.64
20180.64
Margins
0%20%40%60%2016201720182019202020212022202320242025
ELV Margins by year
PeriodMargins
202525.56%
202427.85%
202327.44%
202225.51%
202125.96%
202027.75%
201921.52%
201821.94%
20170%
201649.18%
Return on Capital
0%5%10%15%20%2016201720182019202020212022202320242025
ELV Return on Capital by year
PeriodReturn on Capital
202512.86%
202414.44%
202315.19%
202216.22%
202116.9%
202013.77%
201915.15%
201813.14%
201714.5%
20169.84%
Shares Outstanding
0100M200M300M2016201720182019202020212022202320242025
ELV Shares Outstanding by year
PeriodShares Outstanding
2025221.8M
2024227.48M
2023233.07M
2022237.96M
2021241.77M
2020245.4M
2019252.92M
2018257.35M
2017256.08M
2016263.75M
Dividends (USD)
024682017201820192020202120222023202420252026
ELV Dividends (USD) by year
PeriodDividends (USD)
20265.16
20256.84
20246.52
20235.92
20225.12
20214.52
20203.8
20193.2
20183
20172.7
Employee Count
050K100K150K2016201720182019202020212022202320242025
ELV Employee Count by year
PeriodEmployee Count
202597.1K
2024104.2K
2023104.9K
2022102.3K
202198.2K
202083.4K
201970.6K
201863.9K
201756K
201653K
Book Value Per Share (USD)
0501001502002016201720182019202020212022202320242025
ELV Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2025198.49
2024182.11
2023169.07
2022152.67
2021149.43
2020135.28
2019125.45
2018110.9
2017103.49
201695.17
Total Assets (USD)
050B100B150B2016201720182019202020212022202320242025
ELV Total Assets (USD) by year
PeriodTotal Assets (USD)
2025121.49B
2024116.89B
2023108.93B
2022102.75B
202197.46B
202088.28B
201978.25B
201872.47B
201771.46B
201666.39B
PE Ratio
101214161820med 14.58Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELV PE Ratio by year
PeriodPE Ratio
Sep 2618.38
Sep 2617.89
Aug 2617.32
Aug 2617.59
Aug 2617.58
Aug 2617.31
Jul 2616.5
Jul 2616.58
Jul 2616.38
Jul 2617.5
Jul 2617.57
Jun 2616.61
Jun 2616.33
Jun 2616.99
Jun 2617.47
May 2616.53
May 2616.59
May 2616.51
May 2615.89
May 2615.67
Apr 2614.49
Apr 2612.65
Apr 2612.2
Apr 2611.78
Mar 2611.22
Mar 2611.42
Mar 2611.42
Mar 2611.35
Feb 2612.54
Feb 2613.43
Feb 2613.59
Feb 2613.28
Jan 2614.11
Jan 2615.14
Jan 2615.3
Jan 2615.22
Jan 2614.46
Dec 2514.28
Dec 2513.9
Dec 2514.65
Dec 2513.5
Nov 2513.8
Nov 2513.13
Nov 2513.3
Nov 2512.97
Oct 2512.94
Oct 2513.97
Oct 2514.69
Oct 2514.88
Oct 2514.77
Sep 2513.42
Sep 2513.22
Sep 2513.13
Sep 2513.21
Aug 2513.42
Aug 2513.34
Aug 2513.04
Aug 2512.38
Aug 2511.57
Jul 2512.18
Jul 2511.67
Jul 2513.03
Jul 2513.31
Jun 2514.6
Jun 2514.33
Jun 2514.71
Jun 2515.05
May 2514.69
May 2514.24
May 2515.43
May 2515.48
May 2515.69
Apr 2516.13
Apr 2516.15
Apr 2516.73
Apr 2516.32
Mar 2516.43
Mar 2516.25
Mar 2516.01
Mar 2515.58
Feb 2515.1
Feb 2514.65
Feb 2514.13
Feb 2514.21
Jan 2514.37
Jan 2514.56
Jan 2513.99
Jan 2513.84
Jan 2513.49
Dec 2413.47
Dec 2413.29
Dec 2413.85
Dec 2413.87
Nov 2414.78
Nov 2414.62
Nov 2414.55
Nov 2415.34
Nov 2415.03
Oct 2415.44
Oct 2415.64
Free Cash Flow Yield
0%2%4%6%8%10%med 4.85%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELV Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 266.89%
Sep 267.08%
Aug 267.32%
Aug 267.21%
Aug 267.21%
Aug 267.32%
Jul 267.68%
Jul 267.64%
Jul 267.74%
Jul 267.03%
Jul 267%
Jun 267.41%
Jun 267.53%
Jun 267.24%
Jun 267.04%
May 267.44%
May 267.41%
May 267.45%
May 267.74%
May 267.85%
Apr 268.49%
Apr 264.43%
Apr 264.59%
Apr 264.76%
Mar 265%
Mar 264.91%
Mar 264.91%
Mar 264.94%
Feb 264.47%
Feb 264.17%
Feb 264.13%
Feb 264.22%
Jan 264.83%
Jan 264.5%
Jan 264.45%
Jan 264.47%
Jan 264.71%
Dec 254.77%
Dec 254.9%
Dec 254.65%
Dec 255.04%
Nov 254.93%
Nov 255.19%
Nov 255.12%
Nov 255.25%
Oct 255.26%
Oct 254.87%
Oct 256.78%
Oct 256.69%
Oct 256.74%
Sep 257.42%
Sep 257.53%
Sep 257.58%
Sep 257.54%
Aug 257.42%
Aug 257.47%
Aug 257.64%
Aug 258.04%
Aug 258.61%
Jul 258.18%
Jul 258.53%
Jul 254.76%
Jul 254.67%
Jun 254.25%
Jun 254.33%
Jun 254.22%
Jun 254.13%
May 254.23%
May 254.36%
May 254.02%
May 254.01%
May 253.96%
Apr 253.85%
Apr 254.71%
Apr 254.55%
Apr 254.67%
Mar 254.63%
Mar 254.68%
Mar 254.75%
Mar 254.89%
Feb 255.04%
Feb 255.2%
Feb 250.96%
Feb 250.95%
Jan 250.94%
Jan 250.93%
Jan 250.97%
Jan 250.98%
Jan 251.01%
Dec 241.01%
Dec 241.02%
Dec 240.98%
Dec 240.98%
Nov 240.92%
Nov 240.93%
Nov 240.93%
Nov 240.88%
Nov 240.9%
Oct 240.88%
Oct 240.87%
Price to Sales
0.30.40.50.6med 0.43Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELV Price to Sales by year
PeriodPrice to Sales
Sep 260.45
Sep 260.44
Aug 260.43
Aug 260.43
Aug 260.43
Aug 260.43
Jul 260.41
Jul 260.41
Jul 260.4
Jul 260.46
Jul 260.46
Jun 260.43
Jun 260.43
Jun 260.44
Jun 260.46
May 260.43
May 260.43
May 260.43
May 260.42
May 260.41
Apr 260.38
Apr 260.36
Apr 260.35
Apr 260.33
Mar 260.32
Mar 260.32
Mar 260.32
Mar 260.32
Feb 260.36
Feb 260.38
Feb 260.39
Feb 260.38
Jan 260.4
Jan 260.43
Jan 260.43
Jan 260.43
Jan 260.41
Dec 250.41
Dec 250.39
Dec 250.42
Dec 250.38
Nov 250.39
Nov 250.37
Nov 250.38
Nov 250.37
Oct 250.37
Oct 250.4
Oct 250.42
Oct 250.42
Oct 250.42
Sep 250.38
Sep 250.37
Sep 250.37
Sep 250.37
Aug 250.38
Aug 250.38
Aug 250.37
Aug 250.35
Aug 250.33
Jul 250.34
Jul 250.33
Jul 250.42
Jul 250.43
Jun 250.47
Jun 250.46
Jun 250.48
Jun 250.49
May 250.47
May 250.46
May 250.5
May 250.5
May 250.51
Apr 250.52
Apr 250.55
Apr 250.57
Apr 250.55
Mar 250.56
Mar 250.55
Mar 250.54
Mar 250.53
Feb 250.51
Feb 250.5
Feb 250.52
Feb 250.52
Jan 250.53
Jan 250.54
Jan 250.52
Jan 250.51
Jan 250.5
Dec 240.5
Dec 240.49
Dec 240.51
Dec 240.51
Nov 240.54
Nov 240.54
Nov 240.54
Nov 240.57
Nov 240.55
Oct 240.57
Oct 240.58
EV/EBITDA
89101112med 10.01Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELV EV/EBITDA by year
PeriodEV/EBITDA
Sep 2610.59
Sep 2610.28
Aug 269.93
Aug 2610.09
Aug 2610.09
Aug 269.92
Jul 269.42
Jul 269.47
Jul 269.35
Jul 269.87
Jul 269.91
Jun 269.35
Jun 269.19
Jun 269.57
Jun 269.85
May 269.3
May 269.34
May 269.29
May 268.93
May 268.79
Apr 268.1
Apr 269.88
Apr 269.61
Apr 269.37
Mar 269.04
Mar 269.15
Mar 269.16
Mar 269.11
Feb 269.81
Feb 2610.33
Feb 2610.42
Feb 2610.24
Jan 2610.13
Jan 2610.7
Jan 2610.79
Jan 2610.74
Jan 2610.32
Dec 2510.22
Dec 2510.02
Dec 2510.43
Dec 259.79
Nov 259.96
Nov 259.59
Nov 259.68
Nov 259.5
Oct 259.49
Oct 2510.05
Oct 2510.17
Oct 2510.27
Oct 2510.21
Sep 259.48
Sep 259.37
Sep 259.32
Sep 259.36
Aug 259.48
Aug 259.43
Aug 259.27
Aug 258.91
Aug 258.47
Jul 258.8
Jul 258.53
Jul 259.52
Jul 259.68
Jun 2510.41
Jun 2510.26
Jun 2510.47
Jun 2510.66
May 2510.46
May 2510.21
May 2510.88
May 2510.91
May 2511.02
Apr 2511.28
Apr 2511.54
Apr 2511.87
Apr 2511.64
Mar 2511.7
Mar 2511.6
Mar 2511.46
Mar 2511.22
Feb 2510.94
Feb 2510.69
Feb 2510.16
Feb 2510.21
Jan 2510.3
Jan 2510.42
Jan 2510.08
Jan 259.99
Jan 259.78
Dec 249.77
Dec 249.66
Dec 249.99
Dec 2410.01
Nov 2410.54
Nov 2410.45
Nov 2410.41
Nov 2410.88
Nov 2410.7
Oct 2410.94
Oct 2411.06
Price/Operating Cashflow
01020304050med 15.82Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELV Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 2612.22
Sep 2611.9
Aug 2611.51
Aug 2611.69
Aug 2611.69
Aug 2611.51
Jul 2610.97
Jul 2611.03
Jul 2610.89
Jul 2612.06
Jul 2612.11
Jun 2611.45
Jun 2611.26
Jun 2611.71
Jun 2612.04
May 2611.4
May 2611.44
May 2611.38
May 2610.96
May 2610.8
Apr 269.99
Apr 2616.7
Apr 2616.11
Apr 2615.55
Mar 2614.81
Mar 2615.07
Mar 2615.08
Mar 2614.97
Feb 2616.54
Feb 2617.73
Feb 2617.93
Feb 2617.53
Jan 2615.89
Jan 2617.06
Jan 2617.23
Jan 2617.14
Jan 2616.28
Dec 2516.08
Dec 2515.66
Dec 2516.51
Dec 2515.2
Nov 2515.55
Nov 2514.79
Nov 2514.98
Nov 2514.61
Oct 2514.58
Oct 2515.74
Oct 2512.2
Oct 2512.36
Oct 2512.26
Sep 2511.15
Sep 2510.98
Sep 2510.91
Sep 2510.97
Aug 2511.15
Aug 2511.07
Aug 2510.83
Aug 2510.29
Aug 259.61
Jul 2510.11
Jul 259.69
Jul 2515.91
Jul 2516.25
Jun 2517.82
Jun 2517.49
Jun 2517.96
Jun 2518.37
May 2517.93
May 2517.39
May 2518.84
May 2518.9
May 2519.15
Apr 2519.7
Apr 2516.63
Apr 2517.23
Apr 2516.8
Mar 2516.92
Mar 2516.73
Mar 2516.49
Mar 2516.04
Feb 2515.54
Feb 2515.08
Feb 2542.56
Feb 2542.8
Jan 2543.27
Jan 2543.85
Jan 2542.13
Jan 2541.68
Jan 2540.63
Dec 2440.58
Dec 2440.02
Dec 2441.71
Dec 2441.79
Nov 2444.5
Nov 2444.02
Nov 2443.82
Nov 2446.21
Nov 2445.27
Oct 2446.5
Oct 2447.11
Price to Book
11.522.5med 1.93Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELV Price to Book by year
PeriodPrice to Book
Sep 262.03
Sep 261.97
Aug 261.91
Aug 261.94
Aug 261.94
Aug 261.91
Jul 261.82
Jul 261.83
Jul 261.81
Jul 262.08
Jul 262.09
Jun 261.98
Jun 261.94
Jun 262.02
Jun 262.08
May 261.97
May 261.98
May 261.97
May 261.89
May 261.87
Apr 261.73
Apr 261.63
Apr 261.57
Apr 261.52
Mar 261.44
Mar 261.47
Mar 261.47
Mar 261.46
Feb 261.61
Feb 261.73
Feb 261.75
Feb 261.71
Jan 261.77
Jan 261.9
Jan 261.92
Jan 261.91
Jan 261.81
Dec 251.79
Dec 251.75
Dec 251.84
Dec 251.69
Nov 251.73
Nov 251.65
Nov 251.67
Nov 251.63
Oct 251.62
Oct 251.75
Oct 251.8
Oct 251.82
Oct 251.8
Sep 251.64
Sep 251.62
Sep 251.61
Sep 251.62
Aug 251.64
Aug 251.63
Aug 251.59
Aug 251.51
Aug 251.41
Jul 251.49
Jul 251.43
Jul 251.81
Jul 251.85
Jun 252.03
Jun 251.99
Jun 252.04
Jun 252.09
May 252.04
May 251.98
May 252.14
May 252.15
May 252.18
Apr 252.24
Apr 252.33
Apr 252.42
Apr 252.36
Mar 252.37
Mar 252.35
Mar 252.31
Mar 252.25
Feb 252.18
Feb 252.11
Feb 252.07
Feb 252.08
Jan 252.1
Jan 252.13
Jan 252.05
Jan 252.02
Jan 251.97
Dec 241.97
Dec 241.94
Dec 242.03
Dec 242.03
Nov 242.16
Nov 242.14
Nov 242.13
Nov 242.24
Nov 242.2
Oct 242.26
Oct 242.29
Elevance Health Inc.
ELV
Stockpicker

Video analysis: ELV

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ELV

Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation

benzinga.com · 10 Sep 2026

Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation

Elevance Health Inc. (NYSE:ELV) shares are jumping Thursday after the company reaffirmed its full-year 2026 earnings guidance ahead of a series of investor meetings. Here's what you should know.

California State Teachers Retirement System Raises Stake in Elevance Health, Inc. $ELV

defenseworld.net · 7 Sep 2026

California State Teachers Retirement System Raises Stake in Elevance Health, Inc. $ELV

California State Teachers Retirement System boosted its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 37,390.0% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 124,019,670 shares of the company's stock after buying an additional 123,688,863 shares during the quarter. California

Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.

247wallst.com · 5 Sep 2026

Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.

Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.

Allen Mooney & Barnes Investment Advisors LLC Has $17.94 Million Stock Holdings in Elevance Health, Inc. $ELV

defenseworld.net · 4 Sep 2026

Allen Mooney & Barnes Investment Advisors LLC Has $17.94 Million Stock Holdings in Elevance Health, Inc. $ELV

Allen Mooney and Barnes Investment Advisors LLC cut its stake in Elevance Health, Inc. (NYSE: ELV) by 6.5% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,398 shares of the company's stock after selling 3,218 shares during the quarter.

Beaconlight Capital LLC Takes Position in Elevance Health, Inc. $ELV

defenseworld.net · 31 Aug 2026

Beaconlight Capital LLC Takes Position in Elevance Health, Inc. $ELV

Beaconlight Capital LLC bought a new position in shares of Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund bought 5,946 shares of the company's stock, valued at approximately $2,299,000. Elevance Health makes up about 0.8% of Beaconlight Capital LLC's

UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?

zacks.com · 25 Aug 2026

UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?

UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.

Is ELV Undervalued? DCF Says Worth $614

gurufocus.com · 25 Aug 2026

Is ELV Undervalued? DCF Says Worth $614

On August 25, 2026, we delve into the DCF analysis for Elevance Health Inc (ELV), a company that has shown impressive price performance recently, with a year-to

Barrow Hanley Mewhinney & Strauss LLC Takes $175.05 Million Position in Elevance Health, Inc. $ELV

defenseworld.net · 24 Aug 2026

Barrow Hanley Mewhinney & Strauss LLC Takes $175.05 Million Position in Elevance Health, Inc. $ELV

Barrow Hanley Mewhinney and Strauss LLC purchased a new stake in shares of Elevance Health, Inc. (NYSE: ELV) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 452,636 shares of the company's stock, valued at approximately $175,048,000. Barrow Hanley Mewhinney and

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.